Article

Aziz Nazha Discusses the Future of Treating Patients With MDS

Author(s):

Aziz Nazha

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Dr. Rosario Ligestri
image of man.
Dr. Joshua Sabari and Chris Conneran
Related Content
Image of blood cells
September 16th 2025

Venclexta And Azacitidine Fail to Improve MDS Survival

Ariana Pelosci
Dr. Paul Gellhaus says PSA testing and modern biopsy methods ease fears and reassure patients, making early prostate cancer detection safe and valuable.
September 16th 2025

Early Prostate Cancer Detection: Why PSA Screening Matters

Dr. Paul Gellhaus
Hypomethylating agents are underutilized, particularly among older, female and non-White patients with MDS: © stock.adobe.com.
September 16th 2025

HMAs Underutilized in Older, Female and Non-White Patients with MDS

Alex Biese
Kristen Dahlgren of the Cancer Vaccine Coalition spoke with CURE about why she remains hopeful for the future or cancer vaccines.
September 16th 2025

Could Cancer Vaccines Become a Reality Within the Next Decade?

Kristen Dahlgren
Jane Biehl is a 12-year survivor of a very rare form of blood cancer, known as myelodysplastic syndrome (MDS). Catch up on all of Jane’s blogs here!
September 16th 2025

What Helped Me Get Through 15 Years of Cancer

Jane Biehl Ph.D.
Jane Biehl is a 12-year survivor of a very rare form of blood cancer, known as myelodysplastic syndrome (MDS). Catch up on all of Jane’s blogs here!
September 16th 2025

Max The Butterfly: Hope and Resurrection After Cancer

Jane Biehl Ph.D.